Last updated: 26 August 2022 at 8:31pm EST

John Chiminski Net Worth




The estimated Net Worth of John R Chiminski is at least $74.8 Million dollars as of 24 August 2022. Mr. Chiminski owns over 38,934 units of Catalent stock worth over $13,708,221 and over the last 10 years he sold CTLT stock worth over $52,530,814. In addition, he makes $8,514,990 as Chairman of the Board and Chief Executive Officer at Catalent.

Mr. Chiminski CTLT stock SEC Form 4 insiders trading

John has made over 16 trades of the Catalent stock since 2015, according to the Form 4 filled with the SEC. Most recently he sold 38,934 units of CTLT stock worth $4,011,759 on 24 August 2022.

The largest trade he's ever made was exercising 286,358 units of Catalent stock on 1 October 2018 worth over $6,027,836. On average, John trades about 40,851 units every 57 days since 2014. As of 24 August 2022 he still owns at least 229,888 units of Catalent stock.

You can see the complete history of Mr. Chiminski stock trades at the bottom of the page.





John Chiminski biography

John R. Chiminski serves as Chairman of the Board, Chief Executive Officer of the Company. Mr. Chiminski has led Catalent as Chief Executive Officer since March 2009. He joined us after more than 20 years of experience at GE Healthcare in engineering, operations, and senior leadership roles. From 2007 to 2009, Mr. Chiminski was President and Chief Executive Officer of GE Medical Diagnostics, a global business with sales of $1.9 billion. From 2005 to 2007, he served as Vice President and General Manager of GE Healthcare’s Global Magnetic Resonance Business, and from 2001 to 2005, as Vice President and General Manager of Global Healthcare Services. Earlier at GE, he held a series of cross-functional leadership positions in both manufacturing and engineering, including a GE Medical Systems assignment in France. Mr. Chiminski holds a B.S. from Michigan State University and an M.S. from Purdue University, both in electrical engineering, as well as a Master’s degree in Management from the Kellogg School of Management at Northwestern University.

What is the salary of John Chiminski?

As the Chairman of the Board and Chief Executive Officer of Catalent, the total compensation of John Chiminski at Catalent is $8,514,990. There are no executives at Catalent getting paid more.



How old is John Chiminski?

John Chiminski is 55, he's been the Chairman of the Board and Chief Executive Officer of Catalent since 2019. There are 15 older and 12 younger executives at Catalent. The oldest executive at Catalent Inc. is Rolf Classon, 75, who is the Independent Director.

What's John Chiminski's mailing address?

John's mailing address filed with the SEC is C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET, NJ, 08873.

Insiders trading at Catalent

Over the last 10 years, insiders at Catalent have traded over $2,686,980,380 worth of Catalent stock and bought 123,000 units worth $5,376,345 . The most active insiders traders include Management Associates V L.L..., Peter Zippelius, and Frank A Damelio. On average, Catalent executives and independent directors trade stock every 17 days with the average trade being worth of $22,866,018. The most recent stock trade was executed by Ricky Hopson on 2 August 2024, trading 662 units of CTLT stock currently worth $39,429.



What does Catalent do?

catalyst + talent. our name combines these ideas. from drug and biologic development services to delivery technologies to supply solutions, we are the catalyst for your success. with over 80 years of experience, we have the deepest expertise, the broadest offerings, and the most innovative technologies to help you get more molecules to market faster, enhance product performance and provide superior, reliable manufacturing and packaging results. catalent develops. with our broad range of expert services we drive faster, more efficient development timelines to help you take more molecules to market and create more effective products. catalent delivers. as the world leader in drug delivery innovations, we have a proven record of enhancing bioavailability, solubility and permeability, improving ease and route of administration, and increasing patient compliance for better treatments. catalent supplies. globally positioned to serve all your manufacturing and commercial packaging needs, we p



Complete history of Mr. Chiminski stock trades at Catalent and Berkeley Lights

Insider
Trans.
Transaction
Total value
John R Chiminski
Executive Chair
Sale $4,011,759
24 Aug 2022
John R Chiminski
Executive Chair
Sale $1,035,968
26 Jul 2022
John R Chiminski
Executive Chair
Sale $19,980,183
1 Oct 2021
John R Chiminski
Executive Chair
Sale $5,830,597
26 Aug 2021
John R Chiminski
Executive Chair
Sale $1,259,038
26 Jul 2021
John R Chiminski
Executive Chair
Option $9,219,237
18 Mar 2021
John R Chiminski
Executive Chair
Sale $15,673,688
2 Oct 2020
John R Chiminski
Executive Chair
Sale $4,739,580
7 Oct 2019
John R Chiminski
Executive Chair
Option $6,027,836
1 Oct 2018
John R Chiminski
Executive Chair
Option $2,213,596
11 Dec 2017
John R Chiminski
Executive Chair
Option $2,213,586
16 Mar 2017
John R Chiminski
Executive Chair
Option $1,071,000
17 Aug 2015
John R Chiminski
Executive Chair
Option $1,071,000
3 Aug 2015
John R Chiminski
Executive Chair
Option $1,071,000
20 Jul 2015
John R Chiminski
Executive Chair
Option $1,071,000
6 Jul 2015
John R Chiminski
Director
Buy $93,240
11 Mar 2022


Catalent executives and stock owners

Catalent executives and other stock owners filed with the SEC include: